Evaluation of the control of risk factors to develop ATHEROsclerosis in patients treated by general practioners in Belgium and Luxembourg
Not Applicable
Completed
- Conditions
- HypertensionCirculatory System
- Registration Number
- ISRCTN12117571
- Lead Sponsor
- Servier Benelux
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 2337
Inclusion Criteria
1. Age = 18 years
2. Confirmed (in medical records) diagnosis of hypertension
3. Confirmed (in medical records) diagnosis of hypercholesterolemia or stable coronary artery disease
4. Prescription of = 1 antihypertensive drug
5. Prescription of a statin
Exclusion Criteria
Patients hospitalised for cardiovascular diseases in the last 3 months (including revascularization).
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> 1. Systolic and diastolic blood pressure values is measured using according to the general practitioners’ standard operating procedure during consultation<br> 2. LDL-c and total cholesterol is noted based on medical records at time of consultation<br>
- Secondary Outcome Measures
Name Time Method <br> 1. Number of antihypertensive and cholesterol lowering drugs taken before consultation is measured using medical records<br> 2. Cardiovascular risk of on-treatment patients in Belgium and Luxembourg is measured using medical records and patient anamnesis during consultation<br> 3. Judged BP control and cholesterol control is measured by asking the general practitioners’ clinical evaluation during consultation<br> 4. Judgement of the suitability of the patient for single pill combinations & motivation is measured using by asking the general practitioners’ clinical evaluation during consultation<br> 5. Types of antihypertensive and lipid lowering treatment used in Belgium and Luxembourg is measured using medical records<br>